Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385659782> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4385659782 endingPage "S1013" @default.
- W4385659782 startingPage "S1013" @default.
- W4385659782 abstract "Introduction Current clinical guidelines recommend the use of clozapine for the treatment of refractory schizophrenia, present in up to a third of patients with this disease. Despite the evidence, the data point to low prescription, underdosing, and delayed initiation. Objectives The objective of the study is to elucidate which factors may interfere in clozpine prescription. Methods This is a cross-sectional observational study, carried out using a survey designed specifically for it. It was answered online by seventy psychiatrists affiliated with the Catalan Society of Psychiatry. Results More than half admitted having prescribed two or more antipsychotics without having previously ruled out pseudorefractoriness through depot treatment. 70% recognized the need for monitoring as the main prescription barrier, while the main reason for withdrawal was its adverse effects. The most alarming was considered agranulocytosis, with drooling, drowsiness and weight gain being the most reported. Statistically significant differences (p=0.031) were found in relation to the years of experience and the device where clozapine was preferred to be started: <10 years in hospital, 10-20 years in partial hospitalization and >20 years outpatient office. Statistically significant differences were observed in the preference of the device for its initiation depending on the usual work device: hospitalization (p<0.000) and partial hospitalization (p=0.046) preferred to schedule it from their respective devices, without any preference in consultations. The level of experience and the most reported side effect were statistically significant: for the newest psychiatrists it was weight gain (p=0.031), without presenting differences in the rest of the groups. Conclusions Clozapine is the psychoactive drug of choice in refractory schizophrenia, so efforts should be devoted to reducing prescription barriers, offering training on its management and innovating forms of monitoring to promote its use. Disclosure of Interest None Declared" @default.
- W4385659782 created "2023-08-09" @default.
- W4385659782 creator A5036250513 @default.
- W4385659782 creator A5039912465 @default.
- W4385659782 creator A5044415458 @default.
- W4385659782 creator A5065895922 @default.
- W4385659782 creator A5070477939 @default.
- W4385659782 creator A5076037934 @default.
- W4385659782 creator A5092612726 @default.
- W4385659782 date "2023-03-01" @default.
- W4385659782 modified "2023-09-25" @default.
- W4385659782 title "Clinician’s attitude towards clozapine prescription" @default.
- W4385659782 doi "https://doi.org/10.1192/j.eurpsy.2023.2152" @default.
- W4385659782 hasPublicationYear "2023" @default.
- W4385659782 type Work @default.
- W4385659782 citedByCount "0" @default.
- W4385659782 crossrefType "journal-article" @default.
- W4385659782 hasAuthorship W4385659782A5036250513 @default.
- W4385659782 hasAuthorship W4385659782A5039912465 @default.
- W4385659782 hasAuthorship W4385659782A5044415458 @default.
- W4385659782 hasAuthorship W4385659782A5065895922 @default.
- W4385659782 hasAuthorship W4385659782A5070477939 @default.
- W4385659782 hasAuthorship W4385659782A5076037934 @default.
- W4385659782 hasAuthorship W4385659782A5092612726 @default.
- W4385659782 hasBestOaLocation W43856597821 @default.
- W4385659782 hasConcept C118552586 @default.
- W4385659782 hasConcept C126322002 @default.
- W4385659782 hasConcept C147583825 @default.
- W4385659782 hasConcept C159110408 @default.
- W4385659782 hasConcept C187212893 @default.
- W4385659782 hasConcept C194828623 @default.
- W4385659782 hasConcept C197934379 @default.
- W4385659782 hasConcept C23131810 @default.
- W4385659782 hasConcept C2426938 @default.
- W4385659782 hasConcept C2776412080 @default.
- W4385659782 hasConcept C2780320433 @default.
- W4385659782 hasConcept C2780494398 @default.
- W4385659782 hasConcept C2780864610 @default.
- W4385659782 hasConcept C71924100 @default.
- W4385659782 hasConceptScore W4385659782C118552586 @default.
- W4385659782 hasConceptScore W4385659782C126322002 @default.
- W4385659782 hasConceptScore W4385659782C147583825 @default.
- W4385659782 hasConceptScore W4385659782C159110408 @default.
- W4385659782 hasConceptScore W4385659782C187212893 @default.
- W4385659782 hasConceptScore W4385659782C194828623 @default.
- W4385659782 hasConceptScore W4385659782C197934379 @default.
- W4385659782 hasConceptScore W4385659782C23131810 @default.
- W4385659782 hasConceptScore W4385659782C2426938 @default.
- W4385659782 hasConceptScore W4385659782C2776412080 @default.
- W4385659782 hasConceptScore W4385659782C2780320433 @default.
- W4385659782 hasConceptScore W4385659782C2780494398 @default.
- W4385659782 hasConceptScore W4385659782C2780864610 @default.
- W4385659782 hasConceptScore W4385659782C71924100 @default.
- W4385659782 hasIssue "S1" @default.
- W4385659782 hasLocation W43856597821 @default.
- W4385659782 hasOpenAccess W4385659782 @default.
- W4385659782 hasPrimaryLocation W43856597821 @default.
- W4385659782 hasRelatedWork W1973625586 @default.
- W4385659782 hasRelatedWork W1982539986 @default.
- W4385659782 hasRelatedWork W1982699866 @default.
- W4385659782 hasRelatedWork W2003171974 @default.
- W4385659782 hasRelatedWork W2118970553 @default.
- W4385659782 hasRelatedWork W2144557577 @default.
- W4385659782 hasRelatedWork W3093992020 @default.
- W4385659782 hasRelatedWork W3118631796 @default.
- W4385659782 hasRelatedWork W3128346550 @default.
- W4385659782 hasRelatedWork W3215647058 @default.
- W4385659782 hasVolume "66" @default.
- W4385659782 isParatext "false" @default.
- W4385659782 isRetracted "false" @default.
- W4385659782 workType "article" @default.